United Therapeutics Corp. (UTHR) PT Raised to $587 at RBC Capital
Tweet
Share
E-mailGet Alerts UTHR Hot Sheet
Price: $508.48 +1.75%
Rating Summary:
17 Buy, 11 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Rating Summary:
17 Buy, 11 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Join SI Premium – FREE
RBC Capital analyst Lisa Walter raised the price target on United Therapeutics Corp. (NASDAQ: UTHR) to $587.00 (from $569.00) while maintaining a rating.
You May Also Be Interested In
- United Therapeutics completes enrollment in PPF lung fibrosis trial
- Candel Therapeutics Inc. (CADL) PT Raised to $15 at Freedom Broker
- E Ink Holdings Inc (8069:TT) PT Lowered to NT$200 at Macquarie
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
